# Cryoport share price today (Cryoport, Inc., CYRX)

> Cryoport, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. CYRX · Industrials · Integrated Freight & Logistics · data as of 4 November 2026. Page: https://www.sectoralpha.in/us/stocks/cyrx

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $16.70 (+99.3% in a year)
- P/E: 10.7× (higher than 71% of the last 1 year)
- Revenue (Jun 2026): $49.0 M (+7.7% on a year ago)
- Profit (Jun 2026): −$10.3 M (−109.6% on a year ago)
- Operating margin: −20.4% (+0.8 points on a year ago)
- ROE: 14%, FY25

Biggest thing to watch: the P/E is higher than 71% of its own history, so the multiple has already done part of the work. ## What is the Cryoport share price today? Cryoport, Inc.'s share price was $16.70 at the close on 4 November 2026. That is 24.8% above its average price over the last 200 trading days. In the last 52 weeks it traded between $8 and $18, and at that close it sat 87% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 3 weeks in a row. Over the last 1 year the share price moved +121% while the S&P 500 moved +23%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Cryoport pay? Cryoport, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Cryoport on? Cryoport is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Cryoport profitable? Cryoport, Inc. posted a net loss of $10.3 M in the Jun 2026 quarter. Full-year FY25 profit was $70.3 M. That loss is 20.9% of the quarter's revenue. The same quarter a year earlier earned $107 M. 9 of the last 10 reported quarters were loss-making. Jun 2026 profit was −$10.3 M, −109.6% on a year earlier. ## How much revenue does Cryoport make, and is it growing? Cryoport, Inc. reported $49.0 M of revenue in the Jun 2026 quarter, +7.7% on the same quarter a year earlier. That is the 6th quarter in a row with growth on the year before. Over 4 years it has grown −5.7% a year on average. The last full year, FY25, came in at $176 M. The last four reported quarters add to $186 M. The quarterly figures for FY23 do not add up to the full-year total on file, so those quarters are left out of the charts and sums. FY25 revenue was $176 M, +12.4% on the year before. Recent pace: the last four quarters grew +12.3% on average, against −5.7% a year over the longer run, so this year is growing faster than its own long-run rate. ## How much of every $100 of sales does Cryoport keep? Cryoport, Inc.'s operating margin was −20.4% in the Jun 2026 quarter, 0.8 percentage points higher than the same quarter a year ago. Across 5 years it has been between −35.7% and −8.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +0.8 percentage points on the year while gross margin changed −0.4 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Cryoport's profit turning into cash? Cryoport, Inc.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 its operations used $8.6 M of cash, against $70.3 M of profit. After $16.4 M of spending on assets, free cash was −$25.0 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Cryoport's cash go? Cryoport, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $72.5 M on assets over the last 3 years. Averaged over those years that is 13.7% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $72.5 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Cryoport's P/E ratio, and how does it compare with its own history? Cryoport, Inc.'s P/E is 10.7×, near the high end of its own history: higher than 71% of past readings. Its usual P/E (the middle reading) is 7.5×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Cryoport business getting better or worse? Cryoport, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 6 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Cryoport earn on its capital? Cryoport, Inc. earned a ROE of 14% in FY25. That is up from a low of −44% in FY21. Its return on capital used (ROIC) is 14.4 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 39.9% net margin and 0.23× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 39.9% net margin × 0.23× asset turnover × 1.52× leverage (assets divided by equity) ≈ 13.9% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: −2.5% − 11.9% = −14.4 percentage points. The 11.9% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Cryoport have too much debt? Cryoport, Inc. has total debt of $232 M against shareholder equity of $491 M as of Jun 2026, so its debt is 0.47× its equity. Year by year, that ratio went from 0.67 in FY21 to 0.46 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Cryoport shareholding pattern? 5.5% of Cryoport, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 3.3 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Cryoport from balance-sheet trouble? For Cryoport, Inc., the Z-score is 0.31. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 0.31 is inside the danger zone, so the balance sheet is a real risk. ## How does Cryoport rank in its industry? 47.2 out of 100, rank 9 of 14 in Integrated Freight & Logistics, with 71% of the evidence available. Cryoport, Inc. scores 47.2 out of 100 against the 14 companies it is compared with in Integrated Freight & Logistics, ranking 9. Relative strength against the index is 24.9%, and revenue and profit growth are weak. The four parts add up to the total exactly: 14.8 + 3 + 11.5 + 17.9 = 47.2. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Cryoport compared with? Cryoport ranks 9 of 14 Integrated Freight & Logistics companies on the 4-Factor Sector Score, with 47.2 out of 100. 1. [Expeditors International of Washington, Inc.](https://www.sectoralpha.in/us/stocks/expd) EXPD · leader · Most evidence points up · 81% evidence 67.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 6.8% · Profit 7.6% · Operating margin change 1.4 points · 83% evidence Capital efficiency 20.1/25 · ROCE 46.9% · Operating margin 10.7% · 76% evidence Valuation 7.8/20 · P/E 23.2× · PEG 1.89 · 65% evidence Relative strength 16.9/20 · Lead over its industry 20.2% · Lead over S&P 500 12.9% · 1 year 43.8% · 100% evidence · 11 of 12 weeks ahead Exact sum: 22.4 + 20.1 + 7.8 + 16.9 = 67.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [FedEx Corporation](https://www.sectoralpha.in/us/stocks/fdx) FDX · turning · Most evidence points up · 81% evidence 66.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.4/35 · Revenue 16.6% · Profit 71.5% · Operating margin change 6.6 points · 83% evidence Capital efficiency 13.3/25 · ROCE 9.3% · Operating margin 11.1% · 76% evidence Valuation 13.7/20 · P/E 22.2× · PEG 1.03 · 65% evidence Relative strength 9.2/20 · Lead over its industry 0.3% · Lead over S&P 500 -6.4% · 1 year 25.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 30.4 + 13.3 + 13.7 + 9.2 = 66.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Pitney Bowes Inc.](https://www.sectoralpha.in/us/stocks/pbi) PBI · quiet · Evidence leans up · 64% evidence 62.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.6/35 · Revenue -5.3% · Profit n/a · Operating margin change 6.2 points · 62% evidence Capital efficiency 18.5/25 · ROCE 26.3% · Operating margin 21.7% · 76% evidence Valuation 11.0/20 · P/E 12.7× · PEG n/a · 15% evidence Relative strength 12.6/20 · Lead over its industry 15.3% · Lead over S&P 500 8.1% · 1 year 69.8% · 100% evidence · 2 of 12 weeks ahead Exact sum: 20.6 + 18.5 + 11 + 12.6 = 62.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [United Parcel Service, Inc.](https://www.sectoralpha.in/us/stocks/ups) UPS · turning · Evidence leans up · 81% evidence 56.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.2/35 · Revenue -0.4% · Profit -20.2% · Operating margin change 0.2 points · 83% evidence Capital efficiency 15.2/25 · ROCE 14.7% · Operating margin 9.1% · 76% evidence Valuation 11.4/20 · P/E 20× · PEG 1.58 · 65% evidence Relative strength 15.3/20 · Lead over its industry 10.2% · Lead over S&P 500 2.9% · 1 year 19.1% · 100% evidence · 1 of 12 weeks ahead Exact sum: 14.2 + 15.2 + 11.4 + 15.3 = 56.1 · What this means: Relative strength against the index is 2.9%, and revenue and profit growth are weak. 5. [Radiant Logistics, Inc.](https://www.sectoralpha.in/us/stocks/rlgt) RLGT · turning · Evidence leans up · 81% evidence 52.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.1/35 · Revenue 3.3% · Profit 11.8% · Operating margin change 0.7 points · 83% evidence Capital efficiency 8.0/25 · ROCE 5.9% · Operating margin 2.3% · 76% evidence Valuation 10.0/20 · P/E 22.8× · PEG 1.59 · 65% evidence Relative strength 18.5/20 · Lead over its industry 21.9% · Lead over S&P 500 14.2% · 1 year 57.1% · 100% evidence · 2 of 12 weeks ahead Exact sum: 16.1 + 8 + 10 + 18.5 = 52.6 · What this means: Relative strength against the index is 14.2%, and revenue and profit growth are weak. 6. [J.B. Hunt Transport Services, Inc.](https://www.sectoralpha.in/us/stocks/jbht) JBHT · quiet · Evidence leans up · 85% evidence 50.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue 10.6% · Profit 18% · Operating margin change -1.2 points · 95% evidence Capital efficiency 14.8/25 · ROCE 14.7% · Operating margin 6.7% · 76% evidence Valuation 11.4/20 · P/E 31.1× · PEG 1.34 · 65% evidence Relative strength 3.5/20 · Lead over its industry -2.8% · Lead over S&P 500 -9.3% · 1 year 32.8% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.5 + 14.8 + 11.4 + 3.5 = 50.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [GXO Logistics, Inc.](https://www.sectoralpha.in/us/stocks/gxo) GXO · turning · Evidence leans down · 81% evidence 49.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue 7.5% · Profit 100% · Operating margin change -0.3 points · 83% evidence Capital efficiency 7.3/25 · ROCE 5.7% · Operating margin 3% · 76% evidence Valuation 5.4/20 · P/E 44.5× · PEG 2.21 · 65% evidence Relative strength 15.4/20 · Lead over its industry 9.5% · Lead over S&P 500 2.1% · 1 year 12% · 100% evidence · 1 of 12 weeks ahead Exact sum: 21.4 + 7.3 + 5.4 + 15.4 = 49.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Forward Air Corporation](https://www.sectoralpha.in/us/stocks/fwrd) FWRD · quiet · Evidence leans down · 64% evidence 48.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.0/35 · Revenue -0.1% · Profit n/a · Operating margin change 3.1 points · 62% evidence Capital efficiency 6.2/25 · ROCE 5.6% · Operating margin 6.3% · 76% evidence Valuation 11.3/20 · P/E 9.7× · PEG n/a · 15% evidence Relative strength 11.6/20 · Lead over its industry 0.8% · Lead over S&P 500 -6.2% · 1 year -8.8% · 100% evidence · 9 of 12 weeks ahead Exact sum: 19 + 6.2 + 11.3 + 11.6 = 48.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. Cryoport, Inc. this page CYRX · turning · Evidence leans down · 71% evidence 47.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.8/35 · Revenue 12.7% · Profit -164.8% · Operating margin change 0.8 points · 83% evidence Capital efficiency 3.0/25 · ROCE -5.6% · Operating margin -20.4% · 76% evidence Valuation 11.5/20 · P/E 5.3× · PEG n/a · 15% evidence Relative strength 17.9/20 · Lead over its industry 32.5% · Lead over S&P 500 24.9% · 1 year 99.3% · 100% evidence · 6 of 12 weeks ahead Exact sum: 14.8 + 3 + 11.5 + 17.9 = 47.2 · What this means: Relative strength against the index is 24.9%, and revenue and profit growth are weak. 10. [C.H. Robinson Worldwide, Inc.](https://www.sectoralpha.in/us/stocks/chrw) CHRW · basing · Evidence leans down · 81% evidence 44.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.6/35 · Revenue -0.1% · Profit 18.8% · Operating margin change 0 points · 83% evidence Capital efficiency 17.8/25 · ROCE 24.8% · Operating margin 5.3% · 76% evidence Valuation 8.0/20 · P/E 35.1× · PEG 1.84 · 65% evidence Relative strength 3.3/20 · Lead over its industry -19.5% · Lead over S&P 500 -25.1% · 1 year -10.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 15.6 + 17.8 + 8 + 3.3 = 44.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Hub Group, Inc.](https://www.sectoralpha.in/us/stocks/hubg) HUBG · basing · Too little evidence to rank firmly · 60% evidence 41.8 out of 100 Growth Capital Valuation Relative
12. [Landstar System, Inc.](https://www.sectoralpha.in/us/stocks/lstr) LSTR · quiet · Evidence leans down · 71% evidence 39.9 out of 100 Growth Capital Valuation Relative
13. FedEx Freight Holding Company, Inc. FDXF · quiet · Too little evidence to rank firmly · 51% evidence 31.1 out of 100 Growth Capital Valuation Relative
14. Proficient Auto Logistics, Inc. PAL · Too little evidence to rank firmly · 41% evidence 31.2 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Integrated Freight & Logistics](https://www.sectoralpha.in/us/sectors/integrated-freight-logistics), all 14 compared on one page. ## Which companies are close to Cryoport in size? Cryoport is the 11th largest of 13 Integrated Freight & Logistics companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: GXO Logistics, Inc., Landstar System, Inc., Pitney Bowes Inc. and Hub Group, Inc. Just below it: Forward Air Corporation and Radiant Logistics, Inc. ### Integrated Freight & Logistics companies close in size

1. [GXO Logistics, Inc.](https://www.sectoralpha.in/us/stocks/gxo) $6.4 billion
2. [Landstar System, Inc.](https://www.sectoralpha.in/us/stocks/lstr) $5.1 billion
3. [Pitney Bowes Inc.](https://www.sectoralpha.in/us/stocks/pbi) $2.2 billion
4. [Hub Group, Inc.](https://www.sectoralpha.in/us/stocks/hubg) $1.6 billion
5. Cryoport, Inc. $846 million
6. [Forward Air Corporation](https://www.sectoralpha.in/us/stocks/fwrd) $645 million
7. [Radiant Logistics, Inc.](https://www.sectoralpha.in/us/stocks/rlgt) $450 million

[All 13 Integrated Freight & Logistics companies, largest first](https://www.sectoralpha.in/us/sectors/integrated-freight-logistics#all-companies)

### Companies close in size in other industries

1. [Navient Corporation](https://www.sectoralpha.in/us/stocks/navi) $851 million · Credit Services
2. [SmartFinancial, Inc.](https://www.sectoralpha.in/us/stocks/smbk) $847 million · Banks - Regional
3. Cryoport, Inc. $846 million
4. [Aktis Oncology, Inc.](https://www.sectoralpha.in/us/stocks/akts) $845 million · Biotechnology
5. [Forum Energy Technologies, Inc.](https://www.sectoralpha.in/us/stocks/fet) $845 million · Oil & Gas Equipment & Services

## What else do people ask about Cryoport? ### What were Cryoport's latest quarterly results? Cryoport, Inc. reported revenue of $49.0 M and a net loss of $10.3 M for the Jun 2026 quarter. Revenue rose 7.7% and profit fell 109.6% compared with a year earlier. Earnings per share were −$0.20. The operating margin was −20.4%, 0.8 percentage points higher than a year earlier (as of 4 November 2026). ### What is Cryoport's market cap? Cryoport, Inc.'s market capitalisation is $846 M at a stock price of $16.70. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Cryoport performing? Cryoport, Inc.'s latest readings are below. In its latest quarter, revenue rose 7.7% and profit fell 109.6% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 3 weeks running. This describes what the data did, not a rating (as of 4 November 2026). ### Will Cryoport's stock price go up? This page does not forecast Cryoport, Inc.'s stock price. What it shows instead: the stock price is $16.70. Its P/E of 10.7× is higher than 71% of its own last 1 years. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026). ### Where is Cryoport in its business cycle? Cryoport, Inc.'s FY25 operating margin was −18.0%, against a 5-year range of −35.7% to −8.0%: the middle of its own range, neither a peak nor a low. The latest quarter was −20.4%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Cryoport story? Biggest thing to watch: the P/E is higher than 71% of its own history, so the multiple has already done part of the work. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Cryoport a stock worth studying right now? What the numbers show: Cryoport, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). This is research, not advice. We’re not SEBI-registered.